BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 35380161)

  • 21. The Role of PARPs in Inflammation-and Metabolic-Related Diseases: Molecular Mechanisms and Beyond.
    Ke Y; Wang C; Zhang J; Zhong X; Wang R; Zeng X; Ba X
    Cells; 2019 Sep; 8(9):. PubMed ID: 31500199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noncanonical mono(ADP-ribosyl)ation of zinc finger SZF proteins counteracts ubiquitination for protein homeostasis in plant immunity.
    Kong L; Feng B; Yan Y; Zhang C; Kim JH; Xu L; Rack JGM; Wang Y; Jang JC; Ahel I; Shan L; He P
    Mol Cell; 2021 Nov; 81(22):4591-4604.e8. PubMed ID: 34592134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using Clickable NAD
    Zhang L; Lin H
    Methods Mol Biol; 2017; 1608():95-109. PubMed ID: 28695506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PARPs in genome stability and signal transduction: implications for cancer therapy.
    Palazzo L; Ahel I
    Biochem Soc Trans; 2018 Dec; 46(6):1681-1695. PubMed ID: 30420415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New PARP targets for cancer therapy.
    Vyas S; Chang P
    Nat Rev Cancer; 2014 Jul; 14(7):502-9. PubMed ID: 24898058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uncovering the Invisible: Mono-ADP-ribosylation Moved into the Spotlight.
    Hopp AK; Hottiger MO
    Cells; 2021 Mar; 10(3):. PubMed ID: 33808662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of DNA ADP-ribosyltransferase activities of PARP2 and PARP3: new insights into DNA ADP-ribosylation.
    Zarkovic G; Belousova EA; Talhaoui I; Saint-Pierre C; Kutuzov MM; Matkarimov BT; Biard D; Gasparutto D; Lavrik OI; Ishchenko AA
    Nucleic Acids Res; 2018 Mar; 46(5):2417-2431. PubMed ID: 29361132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleolar-nucleoplasmic shuttling of TARG1 and its control by DNA damage-induced poly-ADP-ribosylation and by nucleolar transcription.
    Bütepage M; Preisinger C; von Kriegsheim A; Scheufen A; Lausberg E; Li J; Kappes F; Feederle R; Ernst S; Eckei L; Krieg S; Müller-Newen G; Rossetti G; Feijs KLH; Verheugd P; Lüscher B
    Sci Rep; 2018 Apr; 8(1):6748. PubMed ID: 29712969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective monitoring of the protein-free ADP-ribose released by ADP-ribosylation reversal enzymes.
    Kasson S; Dharmapriya N; Kim IK
    PLoS One; 2021; 16(6):e0254022. PubMed ID: 34191856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ADP-Ribosylation and Antiviral Resistance in Plants.
    Spechenkova N; Kalinina NO; Zavriev SK; Love AJ; Taliansky M
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MARTs and MARylation in the Cytosol: Biological Functions, Mechanisms of Action, and Therapeutic Potential.
    Challa S; Stokes MS; Kraus WL
    Cells; 2021 Feb; 10(2):. PubMed ID: 33546365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sulfur and nitrogen mustards induce characteristic poly(ADP-ribosyl)ation responses in HaCaT keratinocytes with distinctive cellular consequences.
    Mangerich A; Debiak M; Birtel M; Ponath V; Balszuweit F; Lex K; Martello R; Burckhardt-Boer W; Strobelt R; Siegert M; Thiermann H; Steinritz D; Schmidt A; Bürkle A
    Toxicol Lett; 2016 Feb; 244():56-71. PubMed ID: 26383629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative Determination of MAR Hydrolase Residue Specificity In Vitro by Tandem Mass Spectrometry.
    McPherson RL; Ong SE; Leung AKL
    Methods Mol Biol; 2018; 1813():271-283. PubMed ID: 30097875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Poly(ADP-Ribose) Polymerase Macrodomain Inhibitors Using an AlphaScreen Protocol.
    Ekblad T; Verheugd P; Lindgren AE; Nyman T; Elofsson M; Schüler H
    SLAS Discov; 2018 Apr; 23(4):353-362. PubMed ID: 29316839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PARPs and PAR as novel pharmacological targets for the treatment of stress granule-associated disorders.
    Grimaldi G; Catara G; Palazzo L; Corteggio A; Valente C; Corda D
    Biochem Pharmacol; 2019 Sep; 167():64-75. PubMed ID: 31102582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADP-Ribosyl-Acceptor Hydrolase Activities Catalyzed by the ARH Family of Proteins.
    Mashimo M; Moss J
    Methods Mol Biol; 2018; 1813():187-204. PubMed ID: 30097868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The poly(ADP-ribose) polymerases (PARPs): new roles in intracellular transport.
    Abd Elmageed ZY; Naura AS; Errami Y; Zerfaoui M
    Cell Signal; 2012 Jan; 24(1):1-8. PubMed ID: 21840394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poly(ADP-ribose) signaling in cell death.
    Virág L; Robaszkiewicz A; Rodriguez-Vargas JM; Oliver FJ
    Mol Aspects Med; 2013 Dec; 34(6):1153-67. PubMed ID: 23416893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure of human ADP-ribosyl-acceptor hydrolase 3 bound to ADP-ribose reveals a conformational switch that enables specific substrate recognition.
    Pourfarjam Y; Ventura J; Kurinov I; Cho A; Moss J; Kim IK
    J Biol Chem; 2018 Aug; 293(32):12350-12359. PubMed ID: 29907568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.
    Alemasova EE; Lavrik OI
    Nucleic Acids Res; 2019 May; 47(8):3811-3827. PubMed ID: 30799503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.